Cutting edge: A natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor

Journal of Immunology

Volumn 169, Issue 8, 2002, Pages 4108-4112

  Adriouch, Sahil ^a   Dox, Claudia ^a   Welge, Vivienne ^a   Seman, Michel ^a   Koch Nolte, Friedrich ^a   Haag, Friedrich ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PURINE P2X RECEPTOR; PURINE P2X7 RECEPTOR; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL MEMBRANE; CHANNEL GATING; CYTOPLASM; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; IMMUNE SYSTEM; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

EID: 0037108511     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.8.4108     Document Type: Article

References (35)

1. Gordon, J. L. 1986. Extracellular ATP: effects, sources and fate. Biochem. J. 233:309.
2. Goding, J. W., and M. C. Howard. 1998. Ecto-enzymes of lymphoid cells. Immunol. Rev. 161:5.
3. Adriouch, S., W. Ohlrogge, F. Haag, F. Koch-Nolte, and M. Seman. 2001. Rapid induction of naive T cell apoptosis by ecto-nicotinamide adenine dinucleotide: requirement for mono(ADP-ribosyl)transferase 2 and a downstream effector. J. Immunol. 167:196.
4. Kichenin, K., S. Dccollogne, J. Angignard, and M. Seman. 2000. Cardiovascular and pulmonary response to oral administration of ATP in rabbits. J. Appl. Physiol. 88:1962.
5. Kichenin, K., and M. Seman. 2000. Chronic oral administration of ATP modulates nucleoside transport and purine metabolism in rats. J. Pharmacol. Exp. Ther. 294:126.
6. Buisman, H. P., T. H. Steinberg, J. Fischbarg, S. C. Silverstein, S. A. Vogelzang, C. Ince, D. L. Ypey, and P. C. Leijh. 1988. Extracellular ATP induces a large nonselective conductance in macrophage plasma membranes. Proc. Natl. Acad. Sci. USA 85:7988.
7. Di Virgilio, F., P. Pizzo, P. Zanovello, V. Bronte, and D. Collavo. 1990. Extracellular ATP as a possible mediator of cell-mediated cytotoxicity. Immunol. Today 11:274.
8. Filippini, A., R. E. Taffs, and M. V. Sitkovsky. 1990. Extracellular ATP in T-lymphocyte activation: possible role in effector functions. Proc. Natl. Acad. Sci. USA 87:8267.
9. Blanchard, D. K., S. Wei, C. Duan, F. Pericle, J. I. Diaz, and J. Y. Djeu. 1995. Role of extracellular adenosine triphosphate in the cytotoxic T-lymphocyte-mediated lysis of antigen presenting cells. Blood 85:3173.
10. Di Virgilio, F., P. Chiozzi, D. Ferrari, S. Falzoni, J. M. Sanz, A. Morelli, M. Torboli, G. Bolognesi, and O. R. Baricordi. 2001. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587.
11. Cotrina, M. L., J. H. Lin, A. Alves-Rodrigues, S. Liu, J. Li, H. Azmi-Ghadimi, J. Kang, C. C. Naus, and M. Nedergaard. 1998. Connexins regulate calcium signaling by controlling ATP release. Proc. Natl. Acad. Sci. USA 95:15735.
12. Jiang, Q., D. Mak, S. Devidas, E. M. Schwiebert, A. Bragin, Y. Zhang, W. R. Skach, W. B. Guggino, J. K. Foskett, and J. F. Engelhardt. 1998. Cystic fibrosis transmembrane conductance regulator-associated ATP release is controlled by a chloride sensor. J. Cell Biol. 143:645.
13. Surprenant, A., F. Rassendren, E. Kawashima, R. A. North, and G. Buell. 1996. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735.
14. Rassendren, F., G. N. Buell, C. Virginio, G. Collo, R. A. North, and A. Surprenant. 1997. The permeabilizing ATP receptor, P2X7: cloning and expression of a human cDNA. J. Biol. Chem. 272:5482.
15. Abbracchio, M. P., and G. Burnstock. 1994. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol. Ther. 64:445.
16. 2+ fluxes in J774 macrophages by two distinct mechanisms. J. Biol. Chem. 263:10337.
17. 7 receptors. Br. J. Pharmacol. 130:167.
18. Di Virgilio, F. 1995. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today 16:524.
19. Ferrari, D., M. Los, M. K. Bauer, P. Vandenabeele, S. Wesselborg, and K. Schulze-Osthoff. 1999. P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett. 447:71.
20. Kim, M., L. H. Jiang, H. L. Wilson, R. A. North, and A. Surprenant. 2001. Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J. 20:6347.
21. Denlinger, L. C., P. L. Fisette, J. A. Sommer, J. J. Watters, U. Prabhu, G. R. Dubyak, R. A. Proctor, and P. J. Bertics. 2001. Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J. Immunol. 167:1871.
22. 496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J. Biol. Chem. 276:11135.
23. Wiley, J. S., L. P. Dao-Ung, B. J. Gu, R. Sluyter, A. N. Shemon, C. Li, J. Taper, J. Gallo, and A. Manoharan. 2002. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 359:1114.
24. Hibell, A. D., K. M. Thompson, M. Xing, P. P. Humphrey, and A. D. Michel. 2001. Complexities of measuring antagonist potency at P2X7 receptor orthologs. J. Pharmacol. Exp. Ther. 296:947.
25. Chessell, I. P., J. Simon, A. D. Hibell, A. D. Michel, E. A. Barnard, and P. P. Humphrey. 1998. Cloning and functional characterisation of the mouse P2X7 receptor. FEBS Lett. 439:26.
26. Hibell, A. D., K. M. Thompson, J. Simon, M. Xing, P. P. Humphrey, and A. D. Michel. 2001. Species- and agonist-dependent differences in the deactivation-kinetics of P2X7 receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 363:639.
27. North, R. A., and A. Surprenant, 2000. Pharmacology of cloned P2X receptors. Annu. Rev. Pharmacol. Toxicol. 40:563.
28. Di Virgilio, F., V. Bronte, D. Collavo, and P. Zanovello. 1989. Responses of mouse lymphocytes to extracellular adenosine 5′-triphosphate (ATP): lymphocytes with cytotoxic activity are resistant to the permeabilizing effects of ATP. J. Immunol. 143:1955.
29. Kahl, S., M. Nissen, R. Girisch, T. Duffy, E. H. Leiter, F. Haag, and F. Koch-Nolte. 2000. Metalloprotease-mediated shedding of enzymatically active mouse ecto-ADP-ribosyltransferase ART2.2 upon T cell activation. J. Immunol. 165:4463.
30. Sikora, A., J. Liu, C. Brosnan, G. Buell, I. Chessel, and B. R. Bloom. 1999. Cutting edge: purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism. J. Immunol. 163:558.
31. 7 receptors. J. Biol. Chem. 276:125.
32. Labasi, J. M., N. Petrushova, C. Donovan, S. McCurdy, P. Lira, M. M. Payette, W. Brissette, J. R. Wicks, L. Audoly, and C. A. Gabel. 2002. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168:6436.
33. Ferrari, D., P. Chiozzi, S. Falzoni, M. Dal Susino, L. Melchiorri, O. R. Baricordi, and F. Di Virgilio. 1997. Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159:1451.
34. Sukits, S. F., L. L. Lin, S. Hsu, K. Malakian, R. Powers, and G. Y. Xu. 2001. Solution structure of the tumor necrosis factor receptor-1 death domain. J. Mol. Biol. 310:895.
35. Rost, B., and C. Sander. 1993. Prediction of protein secondary structure at better than 70% accuracy. J. Mol. Biol. 232:584.